AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity
Summary
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
AMITRIPTYLINE |
AMITRIPTYLINE 10mg |
DIN 00370991 |
Tablet |
Amitriptyline Hydrochloride 10mg |
632627, 633441, 638164 |
AMITRIPTYLINE |
AMITRIPTYLINE 50 mg |
DIN 00456349 |
Tablet |
Amitriptyline Hydrochloride 50mg |
633436 |
Issue
Affected lot exceed the acceptable cumulative intake limit for N-nitrosodimethylamine (NDMA) and N-nitroso-nortriptyline (NNORT).
What you should do
Continue taking your medication.
Not treating a condition may pose a greater health risk than potential nitrosamine exposure.
Contact your health care provider:
- to discuss treatment options if you're using a recalled product
- if you have taken a recalled product and are concerned about your health
Ask your pharmacist if you're not sure if the product you're taking has been recalled.
Additional information
Background
Depth of recall: Retailers
Details
|
Pro Doc Ltée 2925 boul. Industriel, Laval, QC, H7L 3W9 |
Get notified
Receive notifications for new and updated recalls and alerts by category.